-
Je něco špatně v tomto záznamu ?
Could hyperlipidemia be a risk factor for corticobasal syndrome? - a pilot study
N. Madetko-Alster, P. Alster, T. Bartošová, J. Klempíř, B. Migda, D. Przewodowska, A. Migda, A. Friedman
Jazyk angličtina Země Polsko
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 2010-01-01
Nursing & Allied Health Database (ProQuest)
od 2010-01-01
Health & Medicine (ProQuest)
od 2010-01-01
Psychology Database (ProQuest)
od 2010-01-01
PubMed
36519660
DOI
10.5603/pjnns.a2022.0078
Knihovny.cz E-zdroje
- MeSH
- hyperlipidemie * MeSH
- kortikobazální degenerace * MeSH
- lidé MeSH
- neurodegenerativní nemoci * etiologie diagnóza patologie MeSH
- pilotní projekty MeSH
- progresivní supranukleární obrna * diagnóza patologie MeSH
- rizikové faktory MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Corticobasal syndrome (CBS) is a specific clinical manifestation shared by multiple pathologies. The exact mechanism of this phenomenon remains unclear. Differential diagnosis of CBS in everyday clinical practice is challenging, as this syndrome can overlap with other entities, especially progressive supranuclear palsy Richardson-Steele phenotype (PSP-RS). Several papers have suggested a possible role of vascular pathology as a linking factor in the pathogenesis of CBS based on different neuropathologies. This paper analyses differences in the occurrence of the most common vascular risk factors such as hypertension and lipid profile with respect to dietary habits among patients who fulfill the diagnostic criteria for probable/possible CBS and PSP-RS. MATERIAL AND METHODS: Seventy (70) patients in total were included in the study. Exclusion criteria comprised hydrocephalus, stroke in the past, the presence of marked vascular changes in white matter defined as the presence of vascular change ≥ 1 mm in 3T MRI, medical history of hyperlipidemia or the use of drugs that could impact upon lipid metabolism before the initiation of the neurodegenerative disease, and neoplastic focuses in the central nervous system. Patients with diabetes, or with BMI exceeding 18-25, or who were smokers, or who were affected by chronic stress were also excluded. Data was analysed statistically using the Shapiro-Wilk test, the U Mann-Whitney test for group comparison, and a Bonferroni correction to control the false discovery rate (FDR). RESULTS: Our obtained results indicated a statistically significantly higher level of total cholesterol in the CBS group (p = 0.0039) without a correlation with dietary habits. CONCLUSIONS AND CLINICAL IMPLICATIONS: The results obtained in our study may suggest a possible role of vascular pathology in CBS development. This issue requires further research.
Department of Internal Medicine and Endocrinology Medical University of Warsaw Warsaw Poland
Department of Neurology Medical University of Warsaw Kondratowicza 8 03 242 Warsaw Poland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010733
- 003
- CZ-PrNML
- 005
- 20250225083047.0
- 007
- ta
- 008
- 230718s2023 pl f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5603/PJNNS.a2022.0078 $2 doi
- 035 __
- $a (PubMed)36519660
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Madetko-Alster, Natalia $u Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03/242 Warsaw, Poland. natalia.madetko@wum.edu.pl $1 https://orcid.org/000000018685475X
- 245 10
- $a Could hyperlipidemia be a risk factor for corticobasal syndrome? - a pilot study / $c N. Madetko-Alster, P. Alster, T. Bartošová, J. Klempíř, B. Migda, D. Przewodowska, A. Migda, A. Friedman
- 520 9_
- $a INTRODUCTION: Corticobasal syndrome (CBS) is a specific clinical manifestation shared by multiple pathologies. The exact mechanism of this phenomenon remains unclear. Differential diagnosis of CBS in everyday clinical practice is challenging, as this syndrome can overlap with other entities, especially progressive supranuclear palsy Richardson-Steele phenotype (PSP-RS). Several papers have suggested a possible role of vascular pathology as a linking factor in the pathogenesis of CBS based on different neuropathologies. This paper analyses differences in the occurrence of the most common vascular risk factors such as hypertension and lipid profile with respect to dietary habits among patients who fulfill the diagnostic criteria for probable/possible CBS and PSP-RS. MATERIAL AND METHODS: Seventy (70) patients in total were included in the study. Exclusion criteria comprised hydrocephalus, stroke in the past, the presence of marked vascular changes in white matter defined as the presence of vascular change ≥ 1 mm in 3T MRI, medical history of hyperlipidemia or the use of drugs that could impact upon lipid metabolism before the initiation of the neurodegenerative disease, and neoplastic focuses in the central nervous system. Patients with diabetes, or with BMI exceeding 18-25, or who were smokers, or who were affected by chronic stress were also excluded. Data was analysed statistically using the Shapiro-Wilk test, the U Mann-Whitney test for group comparison, and a Bonferroni correction to control the false discovery rate (FDR). RESULTS: Our obtained results indicated a statistically significantly higher level of total cholesterol in the CBS group (p = 0.0039) without a correlation with dietary habits. CONCLUSIONS AND CLINICAL IMPLICATIONS: The results obtained in our study may suggest a possible role of vascular pathology in CBS development. This issue requires further research.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a pilotní projekty $7 D010865
- 650 12
- $a kortikobazální degenerace $7 D000088282
- 650 12
- $a neurodegenerativní nemoci $x etiologie $x diagnóza $x patologie $7 D019636
- 650 12
- $a hyperlipidemie $7 D006949
- 650 12
- $a progresivní supranukleární obrna $x diagnóza $x patologie $7 D013494
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Alster, Piotr $u Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03/242 Warsaw, Poland
- 700 1_
- $a Bartošová, Tereza $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University, General University Hospital in Prague, Czech Republic $7 xx0240060
- 700 1_
- $a Klempíř, Jiří $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University, General University Hospital in Prague, Czech Republic
- 700 1_
- $a Migda, Bartosz $u Diagnostic Ultrasound Lab, Department of Pediatric Radiology, Medical Faculty, Medical University of Warsaw, Poland
- 700 1_
- $a Przewodowska, Dominika $u Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03/242 Warsaw, Poland
- 700 1_
- $a Migda, Anna $u Department of Internal Medicine and Endocrinology, Medical University of Warsaw,, Warsaw, Poland
- 700 1_
- $a Friedman, Andrzej $u Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03/242 Warsaw, Poland
- 773 0_
- $w MED00003489 $t Neurologia i neurochirurgia polska $x 0028-3843 $g Roč. 57, č. 2 (2023), s. 177-182
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36519660 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20250225083044 $b ABA008
- 999 __
- $a ok $b bmc $g 1963278 $s 1196998
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 57 $c 2 $d 177-182 $e 20221215 $i 0028-3843 $m Neurologia i Neurochirurgia Polska $n Neurol Neurochir Pol $x MED00003489
- LZP __
- $a Pubmed-20230718